Found 6 matching trials
Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy
PHASE2The study evaluates the safety and effect of intralymphatic allergen specif...
Location
Allergy Unit, Södra Älvsborgs Hospital
Is Intralymphatic Allergen Immunotherapy Effective and Safe?
PHASE215 patients with moderate to severe allergic rhinitis against grass were re...
Location
Allergy Unit, Södra Älvsborgs Hospital
The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma
PHASE2The study evaluates the safety and efficacy of intralymphatic allergen-spec...
Location
Multiple Locations
Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass
PHASE152 patients that had previously participated in the RDBPC study of intralym...
Location
Allergic Unit at the Department of Oto-Rhino-Laryngology at Skåne University Hospital Lund
Intralymphatic Immunotherapy in Increasing Doses, Substudy
PHASE2The study evaluates the safety and effect of intralymphatic allergen specif...
Location
Allergic Unit at the Department of Oto-Rhino-Laryngology at Skåne University Hospital Lund
Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy
PHASE2Allergen-specific immunotherapy (ASIT) is commonly used to treat patients w...
Location
Allergic Unit at the Department of Oto-Rhino-Laryngology at Skåne University Hospital Malmö